Answers are grounded in this paper and cite their sources.
The hybridized mixed-valence isopolyoxomolybdate [N(CH 3 ) 4 ] 5 [Mo V 10 Mo VI 3 (OH) 2 O 37 (C 4 H 4 NO 2 )]·6MeOH ( IDA-Mo V 10 Mo VI 3 ) was synthesized through a solvothermal one-pot method in a non-aqueous environment. The isopolyoxomolybdate scaffold was hybridized with iminodiacetic acid ( IDA ) by chelating a terminal molybdate group. The structural integrity and composition of IDA-Mo V 10 Mo VI 3 were confirmed through comprehensive analyses, including single-crystal X-ray diffraction (XRD), elemental analyses, infrared (IR) spectroscopy, Resonance Raman (RR) spectroscopy, UV-vis spectroscopy, and thermogravimetric analysis (TGA). Bond-valence-sum calculations (BVS) provided evidence that ( IDA-Mo V 10 Mo VI 3 ) is approximately 77% reduced. The high degree of reduction unambiguously places IDA-Mo V 10 Mo VI 3 in the ‘molybdenum-red’ family of highly reduced isopolymolybdates. Initial antiviral and cytotoxicity assays demonstrated good biocompatibility of IDA-Mo V 10 Mo VI 3 , with no observable toxicity and no significant antiviral activity up to 200 µM.
No takes yet. Share an insight, caveat, or question.
Gregorovic et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: